Novartis | Marketskapitalisme



Market Capitalization Endring Dato
AbbVie USD 347.61B 23.02B 2025-05
Alcon AG CHF 38.43B 3.71B 2024-12
Almirall EUR 1.77B 232.92M 2024-12
Amgen USD 150.06B 10.09B 2025-05
AstraZeneca GBP 166.72B 7.79B 2025-05
Biogen USD 17.89B 4.39B 2025-05
Bristol-Myers Squibb USD 101.45B 22.65B 2025-05
Eli Lilly USD 784.52B 42.86B 2025-05
Fresenius EUR 18.89B 438.78M 2024-12
Fresenius Medical Care EUR 12.98B 1.75B 2024-12
Galapagos EUR 1.6B 69.1M 2025-05
Genmab DKK 98.78B 8.42B 2024-12
Gilead Sciences USD 129.47B 10.21B 2025-05
GlaxoSmithKline GBP 60.04B 311.52M 2025-05
GRIFOLS EUR 3.5B 2.19B 2025-05
Hikma Pharmaceutical GBP 4.42B 226.35M 2024-12
J&J USD 374.87B 24.78B 2025-05
Lonza CHF 35.42B 9.08B 2024-06
Merck USD 212.34B 13.54B 2025-05
Novartis CHF 194.25B 18.5B 2024-12
Novo Nordisk A/S 2.12T 551.23B 2024-12
Orion EUR 6.01B 1.71B 2025-05
Pfizer USD 137.09B 6.62B 2025-05
Philips EUR 23.05B 4.37B 2024-12
Regeneron Pharmaceuticals USD 66.6B 2.74B 2025-05
Sanofi EUR 122.48B 3.37B 2025-05



Novartis Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.